Shingles, a painful viral infection previously considered primarily a disease of old age, is now showing an alarming increase among midlife women, according to health experts. While cases across all age groups have been rising since the 1960s, the most significant surge is occurring in women in their 30s, 40s, and 50s. A 2016 study indicated that shingles cases in individuals under 50 had quadrupled from the 1940s to the early 2000s, with women being more susceptible than men across nearly all age brackets.
Shingles is caused by the varicella-zoster virus, the same virus responsible for chickenpox. After an initial infection, the virus lies dormant in the body's nerve cells and can reactivate if the immune system weakens. This reactivation typically occurs due to aging or illness, leading to pain and a characteristic rash on one side of the body or face.
Factors Contributing to Increased Risk
Experts suggest several factors contribute to the heightened risk in midlife women. "Midlife women are more susceptible to shingles on a number of fronts," stated Professor Fatheem Latheef, a consultant dermatologist. "They're more likely to have autoimmune conditions, which increase the risk of shingles." Autoimmune diseases, such as inflammatory arthritis, lupus, and multiple sclerosis, and the medications used to treat them, can impair the immune system's ability to keep the dormant virus in check. This imbalance makes shingles more likely to develop.
Stress is another significant trigger that disproportionately affects women in this age group. Professor Latheef noted that women often face considerable pressure balancing work and family responsibilities, alongside hormonal changes associated with perimenopause and menopause, which can elevate stress levels and make them more prone to shingles. Research indicates that women aged 35 to 54 report the highest levels of stress, often attributed to juggling careers, childcare, and elder care.
High levels of cortisol, the body's primary stress hormone, can suppress parts of the immune system, hindering its ability to control the dormant virus. This can lead to the development of shingles, sometimes following significant life events such as the death of a loved one or an accident, but even chronic lower-level stress can dampen immune function.
Challenges in Diagnosis and Treatment
For younger patients, shingles symptoms can often be missed or misdiagnosed as other conditions like eczema, psoriasis, or bacterial infections, increasing the risk of lasting complications. Early diagnosis is crucial, as antiviral medications are most effective when administered within 72 hours of the rash appearing. Delays in diagnosis can lead to more severe symptoms and a higher likelihood of developing postherpetic neuralgia (PHN), a persistent nerve pain that can linger for months or years.
While Shingrix, a highly effective shingles vaccine, is available, its access is currently limited by the government to adults aged 65 and older, or younger individuals with specific high-risk medical conditions. Those over 50 can opt for private vaccination, which comes at a significant cost.
Prevention and Awareness
Health experts emphasize that maintaining a healthy immune system is key to reducing the risk of shingles. Strategies include getting adequate sleep, eating a balanced diet, engaging in regular exercise, and effectively managing chronic stress. Quitting smoking has also been linked to a reduced risk of shingles.
There is a call for greater awareness campaigns to educate the public, particularly younger adults and midlife women, about the signs and symptoms of shingles. Recognizing the early warning signs, such as tingling or numbness on a patch of skin, is vital for prompt diagnosis and treatment, thereby minimizing the potential for long-term complications and debilitating pain.